UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT
UroGen Pharma Fail-to-Deliver
Total FTD Shares
243
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-49.5%
Negative Trend
FTD Chart
As of Jul 14, 2025,
UroGen Pharma Ltd. has
243
shares failed to deliver, representing 0.01%
of the average daily volume of
3,201,553
shares. Over the past year, the monthly average FTD is
15,089
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 14.49 | 243 | +710.00% |
Jun 30, 2025 | 13.7 | 30 | -98.63% |
May 22, 2025 | 4.08 | 2.19K | +6756.25% |
Apr 30, 2025 | 11.64 | 32 | -99.63% |
Mar 18, 2025 | 11.53 | 8.65K | +27.05% |
Feb 28, 2025 | 9.46 | 6.81K | +668.28% |
Jan 30, 2025 | 11.35 | 886 | -64.49% |
Dec 31, 2024 | 10.65 | 2.5K | -93.59% |
Nov 27, 2024 | 12.66 | 38.94K | +429.01% |
Oct 31, 2024 | 12.26 | 7.36K | +901.36% |
Sep 30, 2024 | 12.7 | 735 | -91.02% |
Aug 27, 2024 | 14.27 | 8.18K | -71.80% |
Jul 26, 2024 | 16.35 | 29.02K | +375.78% |
Jun 28, 2024 | 16.78 | 6.1K | +7429.63% |
May 31, 2024 | 13.3 | 81 | -94.92% |
Apr 30, 2024 | 13.82 | 1.59K | +4.25% |
Mar 27, 2024 | 14.96 | 1.53K | -79.42% |
Feb 27, 2024 | 18.59 | 7.42K | -27.48% |
Jan 29, 2024 | 16.12 | 10.24K | +1098.95% |
Dec 26, 2023 | 14.44 | 854 | -0.47% |
Nov 28, 2023 | 13 | 858 | -5.09% |
Oct 25, 2023 | 11.31 | 904 | -97.00% |
Sep 28, 2023 | 14.29 | 30.18K | +77279.49% |
Aug 14, 2023 | 22.64 | 39 | -99.34% |
Jul 31, 2023 | 21.66 | 5.95K | +313.98% |
Jun 30, 2023 | 10.35 | 1.44K | +70.78% |
May 24, 2023 | 11.2 | 842 | -72.86% |
Apr 28, 2023 | 11.59 | 3.1K | -15.38% |
Mar 31, 2023 | 9.24 | 3.67K | +4318.07% |
Feb 28, 2023 | 10.3 | 83 | -95.29% |
Jan 25, 2023 | 7.99 | 1.76K | n/a |